Lisa Fulcher is a distinguished compliance and ethics executive with over 17 years of experience driving regulatory integrity and risk mitigation across complex industries. As Director of Compliance at Bilfinger, she leads global initiatives in ABAC, internal investigations, and Code of Conduct oversight, embedding ethics into business operations while advancing strategic governance. Known for her pragmatic leadership and commitment to corporate accountability, Lisa is now seeking to contribute her deep expertise at the board level.

In the high-stakes biopharmaceutical industry, where innovation and regulation converge, a robust governance framework is essential for success. Such frameworks provide the structural backbone for clear accountability, regulatory compliance, and effective risk management. Equally critical is fostering a culture of ethics through integrity management, emphasizing ethical leadership, whistleblower protections, and a strong code of conduct. Financial oversight further ensures fiscal responsibility with transparent reporting, internal controls, and precise budget management. By integrating these principles, biopharmaceutical companies can navigate regulatory complexities, build stakeholder trust, and sustain innovation-driven growth.